NDAORALCAPSULE, DELAYED RELEASE
Approved
Oct 2019
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
8
Clinical Trials (5)
A Study to Evaluate Long-Term Safety of Vumerity and Tecfidera in Participants With Multiple Sclerosis (MS)
Started Jun 2024
10,500 enrolled
Multiple Sclerosis
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
Started Oct 2023
908 enrolled
Multiple Sclerosis
A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)
Started Jul 2023
127 enrolled
Relapsing Forms of Multiple Sclerosis
Exploring Diroximel Fumarate Real-world Experience in Canada and Israel
Started Dec 2021
64 enrolled
Relapsing Forms of MS
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Diroximel Fumarate (DRF) in Chinese and Caucasian Adult Healthy Participants
Started Dec 2021
32 enrolled
Healthy Volunteers
Loss of Exclusivity
LOE Date
Oct 29, 2033
93 months away
Patent Expiry
Oct 29, 2033